NMR of amyloidogenic proteins

Protein Misfolding

Volumn , Issue , 2008, Pages 1-39

  Alexandrescu, Andrei T ^a   Croke, Robyn L ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874067106     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (139)

1. Chiti, F. and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease.Annu Rev Biochem. 75,333-366
2. Kelly, J. W. (1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways.Curr Opin Struct Biol.8,101-106
3. Koo, E. H., Lansbury, P. T., Jr. and Kelly, J. W. (1999) Amyloid diseases: abnormal protein aggregation in neurodegeneration.Proc Natl Acad Sci U S A. 96,9989-9990
4. Dobson, C. M. (2003) Protein folding and misfolding.Nature. 426,884-890
5. Cohen, F. E. and Kelly, J. W. (2003) Therapeutic approaches to protein-misfolding diseases.Nature. 426,905-909
6. Alexandrescu, A. T. and Rathgeb-Szabo, K. (1999) An NMR investigation of solution aggregation reactions preceding the misassembly of acid-denatured cold shock protein A into fibrils.J Mol Biol. 291,1191-1206
7. Fandrich, M., Fletcher, M. A. and Dobson, C. M. (2001) Amyloid fibrils from muscle myoglobin.Nature. 410,165-166
8. Lopez De La Paz, M., Goldie, K., Zurdo, J., Lacroix, E., Dobson, C. M., Hoenger, A. and Serrano, L. (2002) De novo designed peptide-based amyloid fibrils.Proc Natl Acad Sci US A. 99,16052-16057
9. Dobson, C. M. (1999) Protein misfolding, evolution and disease.Trends Biochem Sci. 24, 329-332
10. Booth, D. R., Sunde, M., Bellotti, V., Robinson, C. V., Hutchinson, W. L., Fraser, P. E., Hawkins, P. N., Dobson, C. M., Radford, S. E., Blake, C. C. and Pepys, M. B. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.Nature. 385,787-793
11. Johnson, S. M., Wiseman, R. L., Sekijima, Y., Green, N. S., Adamski-Werner, S. L. and Kelly, J. W. (2005) Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses.Acc Chem Res.38,911-921
12. Riek, R., Wider, G., Billeter, M., Hornemann, S., Glockshuber, R. and Wuthrich, K. (1998) Prion protein NMR structure and familial human spongiform encephalopathies.Proc Natl Acad Sci U S A. 95,11667-11672
13. Trinh, C. H., Smith, D. P., Kalverda, A. P., Phillips, S. E. and Radford, S. E. (2002) Crystal structure of monomeric human beta-2-microglobulin reveals clues to its amyloidogenic properties.Proc Natl Acad Sci U S A. 99,9771-9776
14. Eliezer, D., Kutluay, E., Bussell, R., Jr. and Browne, G. (2001) Conformational properties of alpha-synuclein in its free and lipid-associated states.J Mol Biol. 307,1061-1073
15. Hou, L., Shao, H., Zhang, Y., Li, H., Menon, N. K., Neuhaus, E. B., Brewer, J. M., Byeon, I. J., Ray, D. G., Vitek, M. P., Iwashita, T., Makula, R. A., Przybyla, A. B. and Zagorski, M. G. (2004) Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.J Am Chem Soc. 126,1992-2005
16. Williamson, J. A. and Miranker, A. D. (2007) Direct detection of transient alpha-helical states in islet amyloid polypeptide.Protein Sci. 16,110-117
17. Kanaori, K. and Nosaka, A. Y. (1995) Study of human calcitonin fibrillation by proton nuclear magnetic resonance spectroscopy.Biochemistry. 34,12138-12143
18. Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E., Neuenschwander, A., Abramowski, D., Frey, P., Jaton, A. L., Vigouret, J. M., Paganetti, P., Walsh, D. M., Mathews, P. M., Ghiso, J., Staufenbiel, M., Walker, L. C. and Jucker, M. (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host.Science. 313,1781-1784
19. Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J. and Hyman, B. T. (2008) Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease.Nature. 451,720-724
20. Chimon, S., Shaibat, M. A., Jones, C. R., Calero, D. C., Aizezi, B. and Ishii, Y. (2007) Evidence of fibril-like beta-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's beta-amyloid.Nat Struct Mol Biol. 14,1157-1164
21. Ferreira, S. T., Vieira, M. N. and De Felice, F. G. (2007) Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life.59,332-345
22. Lansbury, P. T. and Lashuel, H. A. (2006) A century-old debate on protein aggregation and neurodegeneration enters the clinic.Nature. 443, 774-779
23. Ross, C. A. and Poirier, M. A. (2004) Protein aggregation and neurodegenerative disease.Nat Med. 10 Suppl, S10-17
24. Donahue, J. E., Berzin, T. M., Rafii, M. S., Glass, D. J., Yancopoulos, G. D., Fallon, J. R. and Stopa, E. G. (1999) Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma.Proc Natl Acad Sci USA. 96,6468-6472
25. Bush, A. I. (2003) The metallobiology of Alzheimer's disease.Trends Neurosci. 26,207-214
26. Zhang, Q., Powers, E. T., Nieva, J., Huff, M. E., Dendle, M. A., Bieschke, J., Glabe, C. G., Eschenmoser, A., Wentworth, P., Jr., Lerner, R. A. and Kelly, J. W. (2004) Metabolite-initiated protein misfolding may trigger Alzheimer's disease.Proc Natl Acad Sci U S A. 101,4752-4757
27. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T. and Lansbury, P. T., Jr. (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature.418,291
28. Ernst, R. L. and Hay, J. W. (1994) The US economic and social costs of Alzheimer's disease revisited.Am J Public Health. 84,1261-1264
29. Bush, A. I. (2002) Metal complexing agents as therapies for Alzheimer's disease.NeurobiolAging. 23,1031-1038
30. Cotman, S. L., Halfter, W. and Cole, G. J. (2000) Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain.Mol Cell Neurosci. 15,183-198
31. Selkoe, D. J. (2001) Presenilin, Notch, and the genesis and treatment of Alzheimer's disease.Proc Natl Acad Sci US A. 98,11039-11041
32. Kayed, R., Head, E., Thompson, J. L., Mclntire, T. M., Milton, S. C., Cotman, C. W. and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.Science. 300,486-489
33. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A. and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.Proc Natl Acad Sci U S A. 95, 6448-6453
34. George, J. M. (2002) The synucleins.Genome Biol.3, REVIEWS3002
35. Cookson, M. R. (2005) The biochemistry of Parkinson's disease.Annu Rev Biochem. 74,29-52
36. Moore, D. J., West, A. B., Dawson, V. L. and Dawson, T. M. (2005) Molecular pathophysiology of Parkinson's disease.Annu Rev Neurosci. 28,57-87
37. Goedert, M. (2001) Alpha-synuclein and neurodegenerative diseases.Nat Rev Neurosci. 2,492-501
38. Fink, A. L. (2006) The aggregation and fibrillation of alpha-synuclein.Acc Chem Res. 39, 628-634
39. Conway, K. A., Lee, S. J., Rochet, J. C., Ding, T. T., Williamson, R. E. and Lansbury, P. T., Jr. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.Proc Natl Acad Sci US A. 97,571-576
40. El-Agnaf, O. M., Salem, S. A., Paleologou, K. E., Cooper, L. J., Fullwood, N. J., Gibson, M. J., Curran, M. D., Court, J. A., Mann, D. M., Ikeda, S., Cookson, M. R., Hardy, J. and Allsop, D. (2003) Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.Faseb J. 17,1945-1947
41. Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A. and Lansbury, P. T., Jr. (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.Biochemistry. 35,13709-13715
42. Wuthrich, K. (2003) NMR studies of structure and function of biological macromolecules (Nobel lecture).Angew Chem Int Ed Engl. 42,3340-3363
43. Shortle, D. R. (1996) Structural analysis of non-native states of proteins by NMR methods.Curr Opin Struct Biol.6, 24-30
44. Alexandrescu, A. T. (2001) An NMR-based quenched hydrogen exchange investigation of model amyloid fibrils formed by cold shock protein A.Pac Symp Biocomput,67-78
45. McDermott, A. E. (2004) Structural and dynamic studies of proteins by solid-state NMR spectroscopy: rapid movement forward.Curr Opin Struct Biol. 14,554-561
46. Tycko, R. (2006) Molecular structure of amyloid fibrils: insights from solid-state NMR.Q Rev Biophys. 39,1-55
47. Luhrs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Dobeli, H., Schubert, D. and Riek, R. (2005) 3D structure of Alzheimer's amyloid-beta(1-42) fibrils.Proc Natl Acad Sci U S A. 102,17342-17347
48. Petkova, A. T., Yau, W. M. and Tycko, R. (2006) Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils.Biochemistry. 45,498-512
49. Ferguson, N., Becker, J., Tidow, H., Tremmel, S., Sharpe, T. D., Krause, G., Flinders, J., Petrovich, M., Berriman, J., Oschkinat, H. and Fersht, A. R. (2006) General structural motifs of amyloid protofilaments.Proc Natl Acad Sci U S A. 103,16248-16253
50. Zhang, J., Yarowsky, P., Gordon, M. N., Di Carlo, G., Munireddy, S., van Zijl, P. C. and Mori, S. (2004) Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging.Magn ResonMed. 51,452-457
51. Kiss, E., Keusch, G., Zanetti, M., Jung, T., Schwarz, A., Schocke, M., Jaschke, W. and Czermak, B. V. (2005) Dialysis-related amyloidosis revisited.AJR Am J Roentgenol. 185,1460-1467
52. Whitwell, J. L. and Jack, C. R., Jr. (2007) Neuroimaging in dementia.Neurol Clin. 25,843-857, viii
53. Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R. and Wuthrich, K. (1996) NMR structure of the mouse prion protein domain PrP(121-321).Nature. 382,180-182
54. Cobb, N. J., Sonnichsen, F. D., McHaourab, H. and Surewicz, W. K. (2007) Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.Proc Natl Acad Sci U S A. 104,18946-18951
55. Bai, Y., Milne, J. S., Mayne, L. and Englander, S. W. (1994) Protein stability parameters measured by hydrogen exchange.Proteins. 20,4-14
56. Dempsey, C. E. (2001) Hydrogen exchange in peptides and proteins using NMR spectroscopy.Progress in Nuclear Magnetic Resonance Spectroscopy. 39,135-170
57. Liu, K., Kelly, J. W. and Wemmer, D. E. (2002) Native state hydrogen exchange study of suppressor and pathogenic variants of transthyretin.J Mol Biol. 320,821-832
58. Dumoulin, M., Canet, D., Last, A. M., Pardon, E., Archer, D. B., Muyldermans, S., Wyns, L., Matagne, A., Robinson, C. V., Redfield, C. and Dobson, C. M. (2005) Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.J Mol Biol. 346,773-788
59. Liu, H., Farr-Jones, S., Ulyanov, N. B., Llinas, M., Marqusee, S., Groth, D., Cohen, F. E., Prusiner, S. B. and James, T. L. (1999) Solution structure of Syrian hamster prion protein rPrP(90-231).Biochemistry. 38,5362-5377
60. Shipp, E. L., Cantini, F., Bertini, I., Valentine, J. S. and Banci, L. (2003) Dynamic properties of the G93A mutant of copper-zinc superoxide dismutase as detected by NMR spectroscopy: implications for the pathology of familial amyotrophic lateral sclerosis.Biochemistry. 42,1890-1899
61. Palmer, A. G., III. (2001) Nmr probes of molecular dynamics: overview and comparison with other techniques.Annu Rev Biophys Biomol Struct.30, 129-155
62. Alexandrescu, A. T., Jahnke, W., Wiltscheck, R. and Blommers, M. J. (1996) Accretion of structure in staphylococcal nuclease: an 15N NMR relaxation study.J Mol Biol. 260,570-587
63. Wang, Y. and Shortle, D. (1996) A dynamic bundle of four adjacent hydrophobic segments in the denatured state of staphylococcal nuclease.Protein Sci. 5,1898-1906
64. Alexandrescu, A. T., Lamour, F. P. and Jaravine, V. A. (2000) NMR evidence for progressive stabilization of native-like structure upon aggregation of acid-denatured LysN. J Mol Biol.295,239-255
65. Croke, R. L., Sallum, C. O., Watson, E. and Alexandrescu, A. T. (2008) Hydrogen exchange of monomeric a-synuclein shows the unfolded structure is retained at physiological temperature and is independent of molecular crowding in Escherichia coli.Protein Sci., in press.
66. McParland, V. J., Kalverda, A. P., Homans, S. W. and Radford, S. E. (2002) Structural properties of an amyloid precursor of beta(2)-microglobulin.Nat Struct Biol.9, 326-331
67. Hoshino, M., Katou, H., Hagihara, Y., Hasegawa, K., Naiki, H. and Goto, Y. (2002) Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange.Nat Struct Biol.9, 332-336
68. Alexandrescu, A. T., Abeygunawardana, C. and Shortle, D. (1994) Structure and dynamics of a denatured 131-residue fragment of staphylococcal nuclease: a heteronuclear NMR study.Biochemistry. 33,1063-1072
69. Riek, R., Guntert, P., Dobeli, H., Wipf, B. and Wuthrich, K. (2001) NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox).Eur J Biochem. 268,5930-5936
70. Eliezer, D., Barre, P., Kobaslija, M., Chan, D., Li, X. and Heend, L. (2005) Residual structure in the repeat domain of tau: echoes of microtubule binding and paired helical filament formation.Biochemistry. 44,1026-1036
71. Mukrasch, M. D., Biernat, J., von Bergen, M., Griesinger, C., Mandelkow, E. and Zweckstetter, M. (2005) Sites of tau important for aggregation populate {beta}-structure and bind to microtubules and polyanions.J Biol Chem. 280,24978-24986
72. Watson, A. A., Fairlie, D. P. and Craik, D. J. (1998) Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?Biochemistry. 37,12700-12706
73. Louhivuori, M., Paakkonen, K., Fredriksson, K., Permi, P., Lounila, J. and Annila, A. (2003) On the origin of residual dipolar couplings from denatured proteins.J Am Chem Soc. 125,15647-15650
74. Danielsson, J., Andersson, A., Jarvet, J. and Graslund, A. (2006) 15N relaxation study of the amyloid beta-peptide: structural propensities and persistence length.Magn Reson Chem. 44 Spec No, S114-121
75. Yan, Y. and Wang, C. (2006) Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.J Mol Biol. 364,853-862
76. Danielsson, J., Pierattelli, R., Banci, L. and Graslund, A. (2007) High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.FEBS J. 274,46-59
77. Hou, L. and Zagorski, M. G. (2006) NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.J Am Chem Soc. 128,9260-9261
78. Williamson, M. P., Suzuki, Y., Bourne, N. T. and Asakura, T. (2006) Binding of amyloid beta-peptide to ganglioside micelles is dependent on histidine-13.Biochem J.397,483-490
79. Petkova, A. T., Buntkowsky, G., Dyda, F., Leapman, R. D., Yau, W. M. and Tycko, R. (2004) Solid state NMR reveals a pH-dependent antiparallel beta-sheet registry in fibrils formed by a beta-amyloid peptide.J Mol Biol. 335,247-260
80. Lazo, N. D., Grant, M. A., Condron, M. C., Rigby, A. C. and Teplow, D. B. (2005) On the nucleation of amyloid beta-protein monomer folding.Protein Sci. 14,1581-1596
81. McLaurin, J., Franklin, T., Zhang, X., Deng, J. and Fraser, P. E. (1999) Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.Eur J Biochem. 266,1101-1110
82. Yan, Y. and Wang, C. (2007) Abeta40 protects non-toxic Abeta42 monomer from aggregation.J Mol Biol. 369,909-916
83. Narayanan, S. and Reif, B. (2005) Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions.Biochemistry. 44,1444-1452
84. McNulty, B. C., Tripathy, A., Young, G. B., Charlton, L. M., Orans, J. and Pielak, G. J. (2006) Temperature-induced reversible conformational change in the first 100 residues of alpha-synuclein.Protein Sci. 15,602-608
85. Bertoncini, C. W., Jung, Y. S., Fernandez, C. O., Hoyer, W., Griesinger, C., Jovin, T. M. and Zweckstetter, M. (2005) Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein.Proc Natl Acad Sci U S A. 102,1430-1435
86. Bussell, R., Jr. and Eliezer, D. (2001) Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein.J Biol Chem. 276,45996-46003
87. Bernado, P., Bertoncini, C. W., Griesinger, C., Zweckstetter, M. and Blackledge, M. (2005) Defining long-range order and local disorder in native alpha-synuclein using residual dipolar couplings.J Am Chem Soc. 127,17968-17969
88. Cho, M. K., Kim, H. Y., Bernado, P., Fernandez, C. O., Blackledge, M. and Zweckstetter, M. (2007) Amino acid bulkiness defines the local conformations and dynamics of natively unfolded alpha-synuclein and tau. J Am Chem Soc.129,3032-3033
89. Sung, Y. H. and Eliezer, D. (2007) Residual structure, backbone dynamics, and interactions within the synuclein family.J Mol Biol. 372,689-707
90. Dedmon, M. M., Lindorff-Larsen, K., Christodoulou, J., Vendruscolo, M. and Dobson, C. M. (2005) Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations.J Am Chem Soc. 127,476-477
91. Clore, G. M., Tang, C. and Iwahara, J. (2007) Elucidating transient macromolecular interactions using paramagnetic relaxation enhancement.Curr Opin Struct Biol. 17,603-616
92. Fernandez, C. O., Hoyer, W., Zweckstetter, M., Jares-Erijman, E. A., Subramaniam, V., Griesinger, C. and Jovin, T. M. (2004) NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation.EMBO J. 23,2039-2046
93. McNulty, B. C., Young, G. B. and Pielak, G. J. (2006) Macromolecular crowding in the Escherichia coli periplasm maintains alpha-synuclein disorder.J Mol Biol.355, 893-897
94. Marsh, J. A., Singh, V. K., Jia, Z. and Forman-Kay, J. D. (2006) Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation.Protein Sci. 15,2795-2804
95. Hwang, T. L., van Zijl, P. C. and Mori, S. (1998) Accurate quantitation of water-amide proton exchange rates using the phase-modulated CLEAN chemical EXchange (CLEANEX-PM) approach with a Fast-HSQC (FHSQC) detection scheme.J Biomol NMR. 11,221-226
96. Shimba, N., Serber, Z., Ledwidge, R., Miller, S. M., Craik, C. S. and Dotsch, V. (2003) Quantitative identification of the protonation state of histidines in vitro and in vivo.Biochemistry.42, 9227-9234
97. Rasia, R. M., Bertoncini, C. W., Marsh, D., Hoyer, W., Cherny, D., Zweckstetter, M., Griesinger, C., Jovin, T. M. and Fernandez, C. O. (2005) Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease.Proc Natl Acad Sci US A. 102,4294-4299
98. Sung, Y. H., Rospigliosi, C. and Eliezer, D. (2006) NMR mapping of copper binding sites in alpha-synuclein.Biochim Biophys Acta. 1764,5-12
99. Binolfi, A., Rasia, R. M., Bertoncini, C. W., Ceolin, M., Zweckstetter, M., Griesinger, C., Jovin, T. M. and Fernandez, C. O. (2006) Interaction of alpha-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement.J Am Chem Soc. 128,9893-9901
100. Mandal, P. K., Pettegrew, J. W., Masliah, E., Hamilton, R. L. and Mandal, R. (2006) Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease.Neurochem Res. 31,1153-1162
101. Mandal, P. K. and Pettegrew, J. W. (2007) “Interaction between Abeta Peptide and alpha Synuclein: Molecular Mechanisms in Overlapping Pathology of Alzheimer's and Parkinson's in Dementia with Lewy Body Disease”.Neurochem Res 33,220
102. Fredenburg, R. A., Rospigliosi, C., Meray, R. K., Kessler, J. C., Lashuel, H. A., Eliezer, D. and Lansbury, P. T., Jr. (2007) The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states.Biochemistry.46, 7107-7118
103. Bertoncini, C. W., Rasia, R. M., Lamberto, G. R., Binolfi, A., Zweckstetter, M., Griesinger, C. and Fernandez, C. O. (2007) Structural characterization of the intrinsically unfolded protein beta-synuclein, a natural negative regulator of alpha-synuclein aggregation.J Mol Biol. 372,708-722
104. Ulmer, T. S., Bax, A., Cole, N. B. and Nussbaum, R. L. (2005) Structure and dynamics of micelle-bound human alpha-synuclein.J Biol Chem. 280,9595-9603
105. Parker, W. and Song, P. S. (1992) Protein structures in SDS micelle-protein complexes.Biophys J. 61,1435-1439
106. Chandra, S., Chen, X., Rizo, J., Jahn, R. and Sudhof, T. C. (2003) A broken alpha -helix in folded alpha -Synuclein.J Biol Chem. 278,15313-15318
107. Jao, C. C., Der-Sarkissian, A., Chen, J. and Langen, R. (2004) Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling.Proc Natl Acad Sci U S A. 101,8331-8336
108. Amodeo, P., Motta, A., Strazzullo, G. and Castiglione Morelli, M. A. (1999) Conformational flexibility in calcitonin: the dynamic properties of human and salmon calcitonin in solution.J Biomol NMR. 13,161-174
109. Barre, P. and Eliezer, D. (2006) Folding of the repeat domain of tau upon binding to lipid surfaces.J Mol Biol. 362,312-326
110. Jarvet, J., Danielsson, J., Damberg, P., Oleszczuk, M. and Graslund, A. (2007) Positioning of the Alzheimer Abeta(1-40) peptide in SDS micelles using NMR and paramagnetic probes.J Biomol NMR. 39,63-72
111. Shao, H., Jao, S., Ma, K. and Zagorski, M. G. (1999) Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.J Mol Biol. 285,755-773
112. Coles, M., Bicknell, W., Watson, A. A., Fairlie, D. P. and Craik, D. J. (1998) Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?Biochemistry. 37,11064-11077
113. Mandal, P. K. and Pettegrew, J. W. (2004) Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with Abeta(1-40) peptide in a membrane mimic environment.Neurochem Res. 29,447-453
114. Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D., Delaglio, F. and Tycko, R. (2002) A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.Proc Natl Acad Sci U S A. 99,16742-16747
115. Marcelino, A. M. and Gierasch, L. M. (2008) Roles of beta-turns in protein folding: From peptide models to protein engineering.Biopolymers. 89,380-391
116. Ulmer, T. S. and Bax, A. (2005) Comparison of structure and dynamics of micelle-bound human alpha-synuclein and Parkinson disease variants.J Biol Chem. 280,43179-43187
117. Chen, Z., Krause, G. and Reif, B. (2005) Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils.J MolBiol.354,760-776
118. Zhang, Y. Z., Paterson, Y. and Roder, H. (1995) Rapid amide proton exchange rates in peptides and proteins measured by solvent quenching and two-dimensional NMR.Protein Sci. 4,804-814
119. Chimon, S. and Ishii, Y. (2005) Capturing intermediate structures of Alzheimer's betaamyloid, Abeta(1-40), by solid-state NMR spectroscopy.J Am Chem Soc. 127,13472-13473
120. Morgan, G. J., Giannini, S., Hounslow, A. M., Craven, C. J., Zerovnik, E., Turk, V., Waltho, J. P. and Staniforth, R. A. (2008) Exclusion of the native alpha-helix from the amyloid fibrils of a mixed alpha/beta protein.J Mol Biol. 375,487-498
121. Whittemore, N. A., Mishra, R., Kheterpal, I., Williams, A. D., Wetzel, R. and Serpersu, E. H. (2005) Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy.Biochemistry. 44,4434-4441
122. Olofsson, A., Lindhagen-Persson, M., Sauer-Eriksson, A. E. and Ohman, A. (2007) Amide solvent protection analysis demonstrates that amyloid-beta(1-40) and amyloid-beta(1-42) form different fibrillar structures under identical conditions.Biochem J. 404, 63-70
123. Olofsson, A., Sauer-Eriksson, A. E. and Ohman, A. (2006) The solvent protection of alzheimer amyloid-beta-(1-42) fibrils as determined by solution NMR spectroscopy.J Biol Chem. 281,477-483
124. Wilson, L. M., Mok, Y. F., Binger, K. J., Griffin, M. D., Mertens, H. D., Lin, F., Wade, J. D., Gooley, P. R. and Howlett, G. J. (2007) A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis.J Mol Biol. 366, 1639-1651
125. Yamaguchi, K., Katou, H., Hoshino, M., Hasegawa, K., Naiki, H. and Goto, Y. (2004) Core and heterogeneity of beta2-microglobulin amyloid fibrils as revealed by H/D exchange.J Mol Biol.338, 559-571
126. Olofsson, A., Ippel, J. H., Wijmenga, S. S., Lundgren, E. and Ohman, A. (2004) Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy.J Biol Chem. 279,5699-5707
127. Kheterpal, I. and Wetzel, R. (2006) Hydrogen/deuterium exchange mass spectrometry--a window into amyloid structure.Acc Chem Res. 39,584-593
128. Alexandrescu, A. T. (2005) Amyloid accomplices and enforcers.Protein Sci. 14,1-12
129. Bai, Y., Sosnick, T. R., Mayne, L. and Englander, S. W. (1995) Protein folding intermediates: native-state hydrogen exchange.Science. 269,192-197.
130. Tycko, R. (2006) Characterization of amyloid structures at the molecular level by solid state nuclear magnetic resonance spectroscopy.Methods Enzymol. 413,103-122
131. Iwata, K., Fujiwara, T., Matsuki, Y., Akutsu, H., Takahashi, S., Naiki, H. and Goto, Y. (2006) 3D structure of amyloid protofilaments of beta2-microglobulin fragment probed by solid-state NMR.Proc Natl Acad Sci U SA.103,18119-18124
132. Sato, T., Kienlen-Campard, P., Ahmed, M., Liu, W., Li, H., Elliott, J. I., Aimoto, S., Constantinescu, S. N., Octave, J. N. and Smith, S. O. (2006) Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.Biochemistry. 45,5503-5516
133. Heise, H., Hoyer, W., Becker, S., Andronesi, O. C., Riedel, D. and Baldus, M. (2005) Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR.Proc Natl Acad Sci U S A. 102,15871-15876
134. Kloepper, K. D., Woods, W. S., Winter, K. A., George, J. M. and Rienstra, C. M. (2006) Preparation of alpha-synuclein fibrils for solid-state NMR: expression, purification, and incubation of wild-type and mutant forms.Protein Expr Purif 48,112-117
135. Kloepper, K. D., Zhou, D. H., Li, Y., Winter, K. A., George, J. M. and Rienstra, C. M. (2007) Temperature-dependent sensitivity enhancement of solid-state NMR spectra of alpha-synuclein fibrils.JBiomol NMR. 39,197-211
136. Kloepper, K. D., Hartman, K. L., Ladror, D. T. and Rienstra, C. M. (2007) Solid-state NMR spectroscopy reveals that water is nonessential to the core structure of alpha-synuclein fibrils.JPhys Chem B. 111,13353-13356
137. Wishart, D. S., Bigam, C. G., Holm, A., Hodges, R. S. and Sykes, B. D. (1995) 1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects.J Biomol NMR. 5,67-81
138. Tomaselli, S., Esposito, V., Vangone, P., van Nuland, N. A., Bonvin, A. M., Guerrini, R., Tancredi, T., Temussi, P. A. and Picone, D. (2006) The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding.Chembiochem.7, 257-2673.
139. Vilar, M., Chou, H-T., Luhrs, T., Maji, S.K., Riek-Loher, D., Verel, R., Manning, G., Stahlberg, H., and Riek, R. (2008) The fold of a-synuclein fibrils.Proc Natl Acad Sci U S A. 105,8637-8642.